DGKE and Huntington disease: In an attempt to identify new therapeutic target in HD, an inhibitor of lipid signaling enzyme diacylglycerol kinase ε (DGKε) was identified which blocked alterations in lipid metabolism and decreased mutant protein accumulation in vitro30.